This site is new - feedback and suggestions welcome via GitHub issues.

#immunotherapy — Friday, May 01, 2026 (14 items)

0 ℹ Ectopic NMDAR expression in cancer unmasks germline-encoded autoimmunity. (nature.com) robot Kleeman SO … Janowitz T Nature 2026-05-01 #antibody #cancer #immunotherapy #autoimmunity #paraneoplastic
0 ℹ Synthetic super-enhancers enable precision viral immunotherapy. (nature.com) robot Koeber U … Pollard SM Nature 2026-05-01 #transcription #immunotherapy #gene therapy #enhancer #glioblastoma
0 ℹ Faecalibacterium prausnitzii enzyme reprograms PD-L1 trafficking and sensitizes colorectal cancer to immunotherapy in mice. (nature.com) robot Ji S … Zhang M Nature Microbiology 2026-05-01 #microbiome #metabolism #immunity #cancer #immunotherapy
0 ℹ The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial. (nature.com) robot Mummery CJ … Salvadore G Nature Medicine 2026-05-01 #antibody #immunotherapy #neurodegeneration #neuroinflammation #microglia
0 ℹ Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial. (nature.com) robot Park W … O'Reilly EM Nature Medicine 2026-05-01 #cancer #immunotherapy #biomarker #pancreatic cancer #parp inhibition
0 ℹ Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study. (nature.com) robot Calabro L … Maio M Nature Genetics 2026-05-01 #methylation #immunotherapy #biomarker #prognosis #mesothelioma
0 ℹ The NPR1 agonist antibody XXB750 in heart failure: a phase 2 randomized trial. (nature.com) robot Solomon SD … Lefkowitz MP Nature Medicine 2026-05-01 #clinical trial #immunotherapy #biomarker #heart failure
0 ℹ CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial. (nature.com) robot DiPersio JF … Cooper BW Nature Medicine 2026-05-01 #immunotherapy #crispr #genome editing #aml #hematopoietic
0 ℹ Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial. (nature.com) robot Mahalingam D … Bekaii-Saab TS Nature Medicine 2026-05-01 #cancer #clinical trial #immunotherapy #chemotherapy #pancreatic
0 ℹ Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial. (nature.com) robot Gay F … Broijl A Nature Medicine 2026-05-01 #antibody #immunotherapy #multiple myeloma #mrd
0 ℹ Facile induction of immune tolerance by an interleukin-2-TGFbeta surrogate agonist. (nature.com) robot Sun Q … Garcia KC Nature 2026-05-01 #immunity #inflammation #immunotherapy #tolerance
0 ℹ A glucocorticoid-FAS axis controls immune evasion during metastatic seeding. (nature.com) robot Cassandras M … Agudo J Nature 2026-05-01 #cancer #immunotherapy #metastasis #immune evasion #tumor microenvironment
0 ℹ Proteasome-guided haem signalling axis contributes to T cell exhaustion. (nature.com) robot Xu Y … Ho PC Nature 2026-05-01 #metabolism #immunity #immunotherapy #exhaustion
0 ℹ Engineered immunosuppressive dendritic cells protect against cardiac remodelling. (nature.com) robot Li X … Hu X Nature 2026-05-01 #inflammation #immunotherapy #tolerance #fibrosis #cardiac